Abstract
In December 2019, the emerging of a new coronavirus-induced pneumonia created a distress among people in China and the international community. This virus was identified as novel coronavirus 2019-nCoV. At the time this Review went to press, the virus has spread to across 27 countries, infecting 17,488 people and caused 362 deaths. The transmission of 2019-nCoV to individuals of different countries is predominantly through close contact with an infected person. Based on the available data, there is a rising trend of infected and death cases. At this point, there is no specific drug or vaccine to treat infected patients besides supportive care. Nevertheless, researchers and doctors around the world have reported the success of using existing antiviral drugs to treat patients.
| Original language | English |
|---|---|
| Article number | a0000068 |
| Journal | Progress in Microbes and Molecular Biology |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 6 Feb 2020 |
| Externally published | Yes |
Keywords
- 2019-nCoV
- Novel Coronavirus
- global pandemic
- supportive care
- treatment
ASJC Scopus subject areas
- Microbiology
- Molecular Biology
- Biochemistry, Genetics and Molecular Biology (miscellaneous)
- Microbiology (medical)
